COVID-19 is an emerging, rapidly evolving situation.
COVID-19 public health info from US CDC | COVID-19 research info from the US NIH | COVID-19 resources for global health researchers
NIH Global Health Funding
In addition to
Fogarty-supported programs and the
trans-NIH programs and collaborations Fogarty is involved in, many Institutes and Centers at NIH offer funding opportunities to support research on global health topics, or in areas relevant to global health.
Current global health funding opportunities from across NIH
- Social Drivers of Mental Illnesses in Low- & Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth
(R01 Clinical Trial Optional) (RFA-MH-21-160)
Expiration Date: March 19, 2021 - International Research Collaboration on Drug Abuse and Addiction Research
(R01 - Clinical Trial Optional) (PA-18-773)
Expiration Date: May 8, 2021 - Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health
(U01 Clinical Trial Optional) (RFA-CA-21-030)
Expiration Date: June 3, 2021 - Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries
(D43 Clinical Trial Not Allowed) (RFA-CA-20-031)
Expiration Date: June 25, 2021 - NIDA Research Education Program for Clinical Researchers and Clinicians
(R25 Clinical Trial Not Allowed) (PAR-19-258)
Expiration Date: September 8, 2021 - Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries
(R01 Clinical Trial Optional) (RFA-MH-21-120)
Expiration Date: November 16, 2021 - Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations
(U01 Clinical Trial Not Allowed) (PAR-20-026) and
(Collaborative U01 Clinical Trial Not Allowed) (PAR-20-027) to accelerate gene discovery for psychiatric disorders in cohorts of non-European ancestry to advance the important goal of global mental health discovery and equity
Expiration date: September 16, 2022 - Co-infection and Cancer
(R01 Clinical Trial Not Allowed) (PAR-20-062) and
(R21 Clinical Trial Not Allowed) (PAR-20-061)
Expiration Date: January 8, 2023 - Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (NOT-CA-20-022)
Applies to due dates on or after May 7, 2020, and subsequent receipt dates through January 8, 2023 - Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions
(G11 Clinical Trial Not Allowed) (PAR-21-037)
Expiration Date: July 29, 2023
Other NIH global health funding resources
Updated February 25, 2021